Habimana Joins Floyd Memorial’s Pain Management Center
NEW ALBANY, IND. Floyd Memorial Hospital’s Pain Management Center has added a new physician to its staff to aid those patients suffering from chronic and acute pain.
Patricia Habimana, MD, a pain management specialist and board certified anesthesiologist, earned her medical degree from the University of Louisville. She completed both her anesthesiology residency and pain management fellowship at the University of Kentucky. Habimana’s professional experience comes from a background in emergency and nuclear medicine, and she has participated in both anesthesiology and physiology clinical research projects. In her practice, her focus is on treating pain using a comprehensive, integrative approach – offering both non-invasive therapies and innovative minimally invasive interventional pain procedures. Habiman is also fluent in English, French, Spanish, and Swahili.
Together with James Brent, MD, and Christian Clasby, MD, the Center operates as a patient-centric program, comprised of a team of physicians with specific area of expertise when it comes to treating pain.
Floyd Memorial Medical Group Adds Rheumatology
NEW ALBANY, IND. Floyd Memorial Medical Group – Rheumatology is now among the list of comprehensive service areas the medical group offers to its patients.
Fellowship-trained rheumatologist Mohsen Ehsan, MD, and nurse practitioner Natalie Lane, FNP-C, make up the former Arthritis Associates of Southern Indiana, now Floyd Memorial Medical Group – Rheumatology. Another provider will be joining the practice this fall.
Ehsan has been serving Kentuckiana’s patients for quite some time. His experience is vast, most notably working as a research physician for the World Health Organization from 1971 – 1972. Ehsan’s fellowships in rheumatology and clinical immunology and connective tissue disease fellowships at Alton Ochsner Medical, New Orleans, and the University of Louisville, respectively, have made him an expert in the care of rheumatic diseases. Ehsan later became a clinical instructor at the University of Louisville’s Arthritis Clinic. With more than 33 years in private practice, Ehsan is well versed in the area of rheumatology.
James Leads Clinical Trial of Therapy for Brain Hemorrhage
LOUISVILLE A Louisville patient is the first to be enrolled in a national clinical trial to test a new treatment for patients who have suffered a ruptured brain aneurysm. The trial, based at the University of Louisville under principal investigator Robert F. James, MD, associate professor in the Department of Neurosurgery at U of L, will include eight other medical centers in the United States.
James, chief of neurosurgery at University of Louisville Hospital, part of KentuckyOne Health, and chief of the Division of Cerebrovascular and Endovascular Neurosurgery at U of L, is leading the ASTROH study, a phase II, randomized clinical trial to determine whether a continuous 14-day, low-dose intravenous infusion of heparin is safe and effective in patients with ruptured brain aneurysms.
The ASTROH study will examine whether the use of intravenous heparin for 14 days following the repair of the ruptured aneurysm will control neuro-inflammation and improve clinical outcomes. Patients who enter University of Louisville Hospital or one of the other participating medical centers having experienced a ruptured brain aneurysm may be evaluated for participation in the trial.
SEND YOUR NEWS ITEMS TO MD-UPDATE > email@example.com